EFFECT OF ANTI-INFLAMMATORY AGENTS ON CAPILLARY PERMEABILITY AND OEDEMA FORMATION.
D064751:Ammonium Compounds; D000818:Animals; D000893:Anti-Inflammatory Agents; D001241:Aspirin; D002199:Capillary Permeability; D002746:Chlorpromazine; D004396:Coloring Agents; D004487:Edema; D006494:Heparin Antagonists; D006854:Hydrocortisone; D051379:Mice; D010600:Pharmacology; D010653:Phenylbutazone; D000644:Quaternary Ammonium Compounds; D012106:Research
D064751:Ammonium Compounds; D000893:Anti-Inflammatory Agents; D004396:Coloring Agents; D006494:Heparin Antagonists; D000644:Quaternary Ammonium Compounds; D010653:Phenylbutazone; D001241:Aspirin; D002746:Chlorpromazine; D006854:Hydrocortisone
AMMONIUM COMPOUNDS; ANTI-INFLAMMATORY AGENTS; ASPIRIN; CAPILLARY PERMEABILITY; CHLORPROMAZINE; DYES; EDEMA; EXPERIMENTAL LAB STUDY; HEPARIN ANTAGONISTS; HYDROCORTISONE; MICE; PHARMACOLOGY; PHENYLBUTAZONE